Exagen
XGN
53 hedge funds and large institutions have $64.1M invested in Exagen in 2025 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 17 increasing their positions, 5 reducing their positions, and 7 closing their positions.
240% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 5
229% more call options, than puts
Call options by funds: $56K | Put options by funds: $17K
214% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 7
186% more capital invested
Capital invested by funds: $22.4M → $64.1M (+$41.7M)
39% more funds holding
Funds holding: 38 → 53 (+15)
7.25% more ownership
Funds ownership: 34.84% → 42.09% (+7.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$4.37M |
| 2 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$2.53M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.33M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$1.34M |
| 5 |
FCM
FourWorld Capital Management
New York
|
+$1.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$1.16M |
| 2 |
Renaissance Technologies
New York
|
-$704K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$598K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$383K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$344K |
XGN Hedge Fund Activity: Q2 2025 in Review
53 of the 7,604 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q2 2025, worth a combined $64.1M — up 186% from $22.4M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new XGN positions and 7 closed out — a net gain of 15 holders — while 17 added to existing stakes and 5 trimmed.
The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $4.37M. The largest seller was Perkins Capital Management, cutting an estimated $1.16M.
- 53 institutional investors held Exagen (XGN) as of Q2 2025, up from 38 in Q1 2025.
- Funds reported $64.1M of Exagen stock for Q2 2025, up 186% quarter-over-quarter.
- 22 funds opened new Exagen positions in Q2 2025 and 7 closed out, a net change of +15 holders.
- The largest Exagen buyer in Q2 2025 was Balyasny Asset Management, an estimated $4.37M added.
- The largest Exagen seller in Q2 2025 was Perkins Capital Management, an estimated $1.16M sold.
Based on aggregated 13F filings for Q2 2025.